|
|
| (4 intermediate revisions not shown.) |
| Line 1: |
Line 1: |
| - | <StructureSection load='1q7b' size='350' side='right' caption='Structure of beta-ketoacyl carrier protein reductase complex with NADP and Ca+2 ion (green) (PDB code [[1q7b]]).' scene='59/593279/Cv/1'>
| + | #REDIRECT [[Beta-hydroxyacyl-acyl_carrier_protein_dehydratase]] |
| - | | + | |
| - | == Function ==
| + | |
| - | | + | |
| - | '''Beta-ketoacyl carrier protein reductase''' (BKACPR) catalyzes the reaction of conversion of 3-hydroxyacyl-[acyl-carrier-protein] to 3-oxoacyl-[acyl-carrier-protein] while using NADPH as a reducing agent. BKACPR is part of the type II fatty acid biosynthesis pathway. '''Pimelyl carrier protein reductase''' (ACPR) is involved in the assembly pathway of the pimeloyl moiety of biotin.
| + | |
| - | | + | |
| - | == Relevance ==
| + | |
| - | | + | |
| - | BKACPR from ''Plasmodium falciparium'' inhibitors are tested as antimalarial drugs. Other BKACPR inhibitors are tested for combating toxoplasmosis and sleeping sickness.
| + | |
| - | | + | |
| - | == Structural highlights ==
| + | |
| - | | + | |
| - | The <scene name='59/593279/Cv/2'>active site</scene> interacting with co-factor NADPH contains the active site catalytic triad <scene name='59/593279/Cv/3'>S138, Y151, K155</scene> (in E. coli, PDB code [[1q7b]]).<ref>PMID:15016358</ref>
| + | |
| - | </StructureSection>
| + | |
| - | | + | |
| - | ==3D structures of beta-ketoacyl carrier protein reductase==
| + | |
| - | | + | |
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
| + | |
| - | {{#tree:id=OrganizedByTopic|openlevels=0|
| + | |
| - | | + | |
| - | *Beta-ketoacyl carrier protein reductase
| + | |
| - | | + | |
| - | **[[1i01]] – EcBKACPR – ''Escherichia coli''<br />
| + | |
| - | **[[1uzl]], [[3lls]] – MtBKACPR – ''Mycobacterium tuberculosis''<br />
| + | |
| - | **[[1uzm]], [[2ntn]] – MtBKACPR (mutant) <br />
| + | |
| - | **[[2p68]], [[2pnf]] – BKACPR – ''Aquifex aeolicus''<br />
| + | |
| - | **[[3f9i]] – BKACPR – ''Rickettsia prowazekii''<br />
| + | |
| - | **[[3osu]] – BKACPR – ''Staphylococcus aureus''<br />
| + | |
| - | **[[3rro]] – VcBKACPR – ''Vibrio cholerae''<br />
| + | |
| - | **[[3u09]], [[4wjz]] – VcBKACPR (mutant) <br />
| + | |
| - | **[[4ijk]] – HpBKACPR – ''Helicobacter pylori'' <br />
| + | |
| - | **[[4afn]] – PaBKACPR – ''Pseudomonas aeruginosa''<br />
| + | |
| - | **[[4fd3]] – yBKACPR - yeast<br />
| + | |
| - | | + | |
| - | *Beta-ketoacyl carrier protein reductase complex
| + | |
| - | | + | |
| - | **[[1q7b]] – EcBKACPR + NADP<br />
| + | |
| - | **[[1q7c]] – EcBKACPR (mutant) + NADP<br />
| + | |
| - | **[[1uzn]] – MtBKACPR (mutant) + NADP<br />
| + | |
| - | **[[2b4q]], [[4ag3]] – PaBKACPR + NADP <br />
| + | |
| - | **[[3rsh]], [[4i08]] – VcBKACPR + NADP <br />
| + | |
| - | **[[4iin]] – HpBKACPR + NAD <br />
| + | |
| - | **[[4fda]], [[4hbg]] – yBKACPR + NADP <br />
| + | |
| - | **[[4bnt]], [[4bnu]], [[4bnv]], [[4bnw]], [[4bnx]], [[4bny]], [[4bnz]], [[4bo0]], [[4bo1]], [[4bo2]], [[4bo3]], [[4bo4]], [[4bo5]], [[4bo6]], [[4bo7]], [[4bo8]], [[4bo9]] – PaBKACPR + inhibitor<br />
| + | |
| - | | + | |
| - | *Specialized beta-ketoacyl carrier protein reductase
| + | |
| - | | + | |
| - | **[[3lmo]] – RpACPR – ''Rhodopseudomonas palustris''<br />
| + | |
| - | **[[2kw2]], [[2ll8]], [[2lpk]] – RpACPR – NMR<br />
| + | |
| - | | + | |
| - | *Pimelyl carrier protein reductase
| + | |
| - | | + | |
| - | **[[4etw]] – ACPR – ''Shigella flexneri''<br />
| + | |
| - | **[[4nmw]] – ACPR – ''Samonella enterica''<br />
| + | |
| - | | + | |
| - | *Enoyl carrier protein reductase see [[Enoyl-Acyl-Carrier Protein Reductase]]
| + | |
| - | }}
| + | |
| - | | + | |
| - | | + | |
| - | | + | |
| - | == References ==
| + | |
| - | <references/>
| + | |
| - | | + | |
| - | [[Category:Topic Page]]
| + | |